Neovacs SA (FR:ALNEV) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Neovacs SA has announced a fundraising initiative of €0.25 million through the issue of OCEANE-BSA securities to finance their Kinoïde research program and bolster investment in biotech and medtech projects. The fundraising could potentially create 500 million new shares, diluting current shareholders’ stakes. The company focuses on developing vaccine candidates and investing in high-potential biotech and medtech companies.
For further insights into FR:ALNEV stock, check out TipRanks’ Stock Analysis page.